Gwenn Hansen - Net Worth and Insider Trading
Gwenn Hansen Net Worth
The estimated net worth of Gwenn Hansen is at least $560,750 dollars as of 2024-05-08. Gwenn Hansen is the Chief Scientific Officer of Nurix Therapeutics Inc and owns about 39,601 shares of Nurix Therapeutics Inc (NRIX) stock worth over $560,750. Details can be seen in Gwenn Hansen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Gwenn Hansen has not made any transactions after 2024-04-30 and currently still holds the listed stock(s).
Transaction Summary of Gwenn Hansen
Gwenn Hansen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gwenn Hansen owns 1 companies in total, including Nurix Therapeutics Inc (NRIX) .
Click here to see the complete history of Gwenn Hansen’s form 4 insider trades.
Insider Ownership Summary of Gwenn Hansen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NRIX | Nurix Therapeutics Inc | 2024-04-30 | Chief Scientific Officer |
Gwenn Hansen Latest Holdings Summary
Gwenn Hansen currently owns a total of 1 stock. Gwenn Hansen owns 39,601 shares of Nurix Therapeutics Inc (NRIX) as of April 30, 2024, with a value of $560,750.
Latest Holdings of Gwenn Hansen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NRIX | Nurix Therapeutics Inc | 2024-04-30 | 39,601 | 14.16 | 560,750 |
Holding Weightings of Gwenn Hansen
Gwenn Hansen Form 4 Trading Tracker
According to the SEC Form 4 filings, Gwenn Hansen has made a total of 20 transactions in Nurix Therapeutics Inc (NRIX) over the past 5 years, including 0 buys and 20 sells. The most-recent trade in Nurix Therapeutics Inc is the sale of 2,007 shares on April 30, 2024, which brought Gwenn Hansen around $24,164.
Insider Trading History of Gwenn Hansen
- 1
Gwenn Hansen Trading Performance
Gwenn Hansen Ownership Network
Gwenn Hansen Owned Company Details
What does Nurix Therapeutics Inc do?
Who are the key executives at Nurix Therapeutics Inc?
Gwenn Hansen is the Chief Scientific Officer of Nurix Therapeutics Inc. Other key executives at Nurix Therapeutics Inc include Chief Financial Officer Houte Hans Van , General Counsel Christine Ring , and EVP and COO Stefani Wolff .
Nurix Therapeutics Inc (NRIX) Insider Trades Summary
Over the past 18 months, Gwenn Hansen made 6 insider transaction in Nurix Therapeutics Inc (NRIX) with a net sale of 10,406. Other recent insider transactions involving Nurix Therapeutics Inc (NRIX) include a net sale of 31,786 shares made by Houte Hans Van , a net sale of 7,455 shares made by Christine Ring , and a net sale of 766 shares made by Stefani Wolff .
In summary, during the past 3 months, insiders sold 15,218 shares of Nurix Therapeutics Inc (NRIX) in total and bought 0 shares, with a net sale of 15,218 shares. During the past 18 months, 50,413 shares of Nurix Therapeutics Inc (NRIX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 50,413 shares.
Nurix Therapeutics Inc (NRIX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nurix Therapeutics Inc Insider Transactions
Gwenn Hansen Mailing Address
Above is the net worth, insider trading, and ownership report for Gwenn Hansen. You might contact Gwenn Hansen via mailing address: C/o Nurix Therapeutics, Inc., 1700 Owens Street, Suite 205, San Francisco Ca 94158.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
